Related Experiment Video
Updated: Sep 7, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Preexisting comorbidities shape the immune response associated with severe COVID-19
Stefanie Kreutmair1, Manuel Kauffmann2, Susanne Unger2
1Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland; German Cancer Consortium and German Cancer Research Center, Heidelberg, Partner Site Freiburg, Freiburg, Germany.
Comorbidities like chronic kidney disease significantly alter immune responses in patients with coronavirus disease 2019 (COVID-19), increasing severe outcomes. Understanding these immune signatures is key to managing COVID-19 risk.
Area of Science:
- Immunology
- Infectious Diseases
- Genomics
Background:
- Comorbidities are known risk factors for severe coronavirus disease 2019 (COVID-19).
- The impact of underlying conditions on the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is not fully understood.
Purpose of the Study:
- To investigate the intricate relationships between comorbidities, immune response, and patient outcomes in COVID-19.
- To identify specific immune signatures associated with various comorbidities and their influence on disease severity.
Main Methods:
- Utilized high-throughput, high-dimensional single-cell mapping of peripheral blood leukocytes.
- Employed algorithm-guided analysis to interpret complex immune data.
Main Results:
- Discovered distinct immune signatures linked to both severe COVID-19 and specific comorbidities.
- Metabolic syndrome factors (obesity, hypertension, diabetes) additively increased immune dysregulation.
- Chronic kidney disease patients exhibited the most altered immune signatures, correlating with a significantly higher risk (OR 16.3) of severe COVID-19.
Conclusions:
- Systematic analysis revealed mechanistic immunologic underpinnings of comorbidity-driven risk in COVID-19.
- Identified specific comorbidity-driven immune signatures that predict patient outcomes.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

